Hunink M G
Department of Health Sciences, Faculty of Medicine, University of Groningen, The Netherlands.
Eur Radiol. 1996;6(5):615-20. doi: 10.1007/BF00187659.
The decision to implement a new medical technology requires that it not only increases survival or quality of life, but that it is also economically sound. The unique feature in the assessment of diagnostic tests is that the results of such tests are intermediate outcomes. Both randomized controlled clinical trials and decision analysis have an important role to play in the assessment of diagnostic tests. Important points to consider when performing a cost-effectiveness study are what perspective to take; comparing the technology with the next best strategy; including both effectiveness and costs; the distinction between describing and valuing the quality of life; intangibles such as the value of information; and the incremental cost-effectiveness ratio.
实施一项新的医疗技术的决策要求该技术不仅能提高生存率或生活质量,而且在经济上也要合理。诊断测试评估的独特之处在于,此类测试的结果属于中间结果。随机对照临床试验和决策分析在诊断测试评估中都发挥着重要作用。进行成本效益研究时需要考虑的要点包括:采用何种视角;将该技术与次优策略进行比较;纳入有效性和成本;区分生活质量的描述和估值;信息价值等无形因素;以及增量成本效益比。